PLYX logo

PLYX
Polaryx Therapeutics Inc.

324
Mkt Cap
$144.87M
Volume
174,776.00
52W High
$48.91
52W Low
$2.20
PE Ratio
-22.35
PLYX Fundamentals
Price
$3.38
Prev Close
$3.06
Open
$3.07
50D MA
$5.35
Beta
0.34
Avg. Volume
169,969.81
EPS (Annual)
-$0.1898
P/B
58.23
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Polaryx Therapeutics (NASDAQ:PLYX) Trading 4.9% Higher - Time to Buy?
Polaryx Therapeutics (NASDAQ:PLYX) Shares Up 4.9% - Here's Why...
MarketBeat·1mo ago
News Placeholder
More News
News Placeholder
Polaryx Therapeutics (NASDAQ:PLYX) Stock Price Down 1.9% - Time to Sell?
Polaryx Therapeutics (NASDAQ:PLYX) Trading Down 1.9% - Time to Sell...
MarketBeat·2mo ago
News Placeholder
Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest?
Watcher count for PLYX on Stocktwits increased by nearly 50% in a single day.
Stocktwits·2mo ago
News Placeholder
Maxim Group Begins Coverage on Polaryx Therapeutics (NASDAQ:PLYX)
Maxim Group began coverage on Polaryx Therapeutics in a report on Friday. They set a "buy" rating and a $10.00 price objective on the stock...
MarketBeat·3mo ago
News Placeholder
Polaryx Therapeutics (NASDAQ:PLYX) Shares Up 15.2% - Here's Why
Polaryx Therapeutics (NASDAQ:PLYX) Shares Up 15.2% - Here's Why...
MarketBeat·3mo ago
News Placeholder
What's Going On With Polaryx Therapeutics Stock Wednesday?
Polaryx Therapeutics Inc. (NASDAQ: PLYX) stock fell after a surge due to a major clinical development announcement.read more...
Benzinga·3mo ago
News Placeholder
Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans
Polaryx Therapeutics (NASDAQ: PLYX) shares rise on selecting research organization for SOTERIA trial to evaluate lead candidate for lysosomal storage disorders.read more...
Benzinga·3mo ago
<
...
1
>

Latest PLYX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.